Related Experiment Video
Updated: Feb 28, 2026
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
New Ruthenium-Based Probes for Selective G-Quadruplex Targeting
Guillaume Piraux1, Laure Bar2, Michaël Abraham1
1Institut de la Matière Condensée et des Nanosciences (IMCN)-Molécules, Solides et Réactivité (MOST), Université catholique de Louvain, Place Louis Pasteur 1, bte L4.01.02, 1348, Louvain-la-Neuve, Belgium.
Abstract:
Telomeric regions containing G-quadruplex (G4) structures play a pivotal role in the development of cancers. The development of specific binders for G4s is thus of great interest in order to gain a deeper understanding of the role of these structures, and to ultimately develop new anticancer drug candidates. For several years, RuII complexes have been studied as efficient probes for DNA. Interest in these complexes stems mainly from the tunability of their structures and properties, and the possibility of using light excitation as a tool to probe their environment or to selectively trigger their reaction with a biological target. Herein, we report on the synthesis and thorough study of new RuII complexes based on a novel dipyrazino[2,3-a:2',3'-h]phenazine ligand (dph), obtained through a Chichibabin-like reaction. Luminescence experiments, surface plasmon resonance (SPR), and computational studies have demonstrated that these complexes behave as selective probes for G-quadruplex structures.
Insights
Researchers developed novel Ruthenium(II) complexes that selectively bind to G-quadruplex (G4) structures. These G4 structures are crucial in cancer development, making these complexes potential tools for cancer research and drug discovery.
Area of Science:
- Coordination Chemistry
- Biophysical Chemistry
- Cancer Biology
Background:
- G-quadruplex (G4) structures in telomeric regions are implicated in cancer development.
- Developing specific G4 binders is crucial for understanding their role and for anticancer drug discovery.
- Ruthenium(II) complexes are versatile DNA probes due to tunable properties and light-excitation capabilities.
Purpose of the Study:
- To synthesize and characterize novel Ruthenium(II) complexes.
- To investigate the potential of these complexes as selective probes for G-quadruplex structures.
- To explore their utility in cancer research and as potential anticancer drug candidates.
Main Methods:
- Synthesis of new Ru(II) complexes featuring a novel dipyrazino[2,3-a:2',3'-h]phenazine (dph) ligand.
- Luminescence spectroscopy to probe interactions.
- Surface Plasmon Resonance (SPR) for binding affinity and selectivity studies.
- Computational modeling to understand complex behavior.
Main Results:
- Successful synthesis of novel Ru(II)-dph complexes.
- Demonstrated selective binding of the complexes to G-quadruplex structures.
- Luminescence and SPR data confirmed G4 recognition.
- Computational studies supported the experimental findings.
Conclusions:
- The novel Ru(II) complexes are effective and selective probes for G-quadruplex DNA.
- These findings open avenues for developing new diagnostic tools and therapeutic strategies targeting G4 structures in cancer.
